跳至主要内容
临床试验/ACTRN12624000521527
ACTRN12624000521527尚未招募2 期

Dropless cataract surgery: assessing the safety and efficacy of intracameral antibiotics and subconjunctival steroid bolus injections on post-operative inflammation

Prof WengOnn Chan0 个研究点目标入组 300 人开始时间: 2024年4月26日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion criteria for this study includes patients over 18 years’ of age who are scheduled to undergo phacoemulsification cataract surgery in the Ophthalmology outpatient department or inpatient setting at the Royal Adelaide Hospital between a designated to be announced (TBA) 6-month period.

排除标准

  • Exclusion criteria for this study includes pregnant patients, patients with prior intraocular surgery, history of steroid-responsive glaucoma, diabetes mellitus and intraoperative complications such as vitreous loss, zonular dialysis and posterior capsular rupture.

研究者

发起方
Prof WengOnn Chan

相似试验